FTSE 100 tumbles again as economists predict US recession

The FTSE 100 tumbled again on Monday as the fallout of Donald Trump’s tariffs continued to rock global equities.

The weekend failed to offer any reprieve from the negative sentiment towards stocks, with many analysts and investors now expecting the US to enter a recession later this year.

London’s leading index fell as much as 6% in the early minutes of trade and remained under pressure as the session progressed.

“The US economy is barrelling rapidly towards recession, and will probably end up taking most of the rest of the world with it,” said Michael Brown Senior Research Strategist at Pepperstone.

“Concurrently, inflation is going to ramp substantially higher for the next couple of quarters, at the very least. Here we are then – stagflation.”

The S&P 500 fell more than 10% over two trading sessions at the end of last week – the biggest two-day drop since the beginning of the pandemic. 

Investors continued to dump European stocks on Monday, and US equities looked set to open lower. 

After such sharp declines at the end of last week, some may have expected a bounce, or at least a pause in selling on Monday. However, the fears about a global recession and little commentary for Trump from the White House over the weekend created an overarching sense of nervousness in markets on Monday.

Hedge fund manager Bill Ackman provided some insight into what he thinks should happen next in a social media post, capturing the attention of equity bulls hoping for a change in approach by Donald Trump. The billionaire suggested delays to tariffs could be announced by Trump, allowing time for deals to be made with other countries, although no such sounds have been made by the Whitehouse yet.

There was a very small and short-lived bounce on Friday when news broke that Trump had a telephone call with Vietnam and discussed the reduction of tariffs. However, claims by the White House that Trump had calls with dozens of other countries over the weekend failed to elicit any meaningful positivity in stocks on Monday. 

Indeed, the initial moves in the FTSE 100 on Monday were nothing short of a bloodbath. All FTSE 100 stocks were down at the time of writing.

Rolls Royce lost another 13% while Glencore sank 12%. Anglo American, Antofagasta, Babcock all fell more than 10%.

The best performers – those with the least declines – were UK-centric housebuilders and supermarkets.


Applied Nutrition beats revenue expectations but profits tumble

Applied Nutrition has made a strong start to life as a listed company by reporting revenues for the six months to 31 January 2025 that were ahead of guidance provided at the time of the IPO.

Revenues for the period were £47.6m – higher than the £46m the supplements and wellbeing company said they expected to generate at the time of the IPO.

“We are pleased to have announced a positive set of maiden results, ahead of what we said we would do at the time of IPO, with the Company delivering strong growth, expanding globally, and driving innovation in our industry,” said Thomas Ryder, CEO of Applied Nutrition.

“This has been a period of significant milestones and progress – our IPO in October, launching our first TV advert to promote our products starring Coleen Rooney, developing relationships with exciting new customers, and expanding into new geographies. The interest in our brand since our IPO has reached new heights and we are very grateful for the strong support we have received from our customers, partners and shareholders.”

Despite revenues growing in the period, Applied Nutrition’s adjusted Ebitda fell 15% to £13.8m in the period and margins contracted. Operating profit fell 28%.

Applied Nutrition’s shares are down materially from their 140p IPO price. Falling profits and lower margins will do little to encourage the share price back up to the listing price.

The company said it is increasing shelf space with major retailers and growing its social media reach through collaborations with celebrities such as Coleen Rooney. These played a part in higher revenues.

Investors, however, will want to see higher revenues translate into higher profits.

Director deals: Filtronic grows with SpaceX

Telecoms and satellite components and systems developer Filtronic (LON: FTC) has been consistently winning new business and chief executive Nat Edgington has added to his shareholding.

He acquired 26,334 shares at 94.88p each, taking his total shareholding to 113,734 shares. In March, he bought an initial 87,400 shares at 114p each. This followed the extension of the strategic agreement with SpaceX.

Nat Edgington has been in his current role since May 2024. He has experience in the technology and semiconductors industry, including at Wolfson Microelectronics.

Business

Telecoms and...

New AIM admission: Wellnex Life expands outside of Australia

ASX-listed consumer healthcare company Wellnex Life Ltd has obtained an additional quotation on AIM. This will help it to finance growth outside of Australia.

The company has a range of its own brands and an agreement with Haleon to sell Panadol products. There are already significant revenues in Australia and potential in other markets, such as the UK and UAE.

On the first day of trading the share price was 31p, but it has declined since then. It has bottomed out at 24p, which is well below the flotation price. A loss is forecast for this year, but the shares are trading on a potential...

AIM weekly movers: Strip Tinning’s recharged battery

0

Dr Graham Cooley has increased his stake in spirits company Distil (LON: DIS) from 16.2% to 17.3%. Steve Xerri had cut his shareholding from 3.78% to under 3%. The share price rebounded 50% to 0.0675p, although it is still 46% lower than at the start of the year.

Automotive and battery connectors supplier Strip Tinning (LON: STG) is expecting a lower than forecast loss in 2025 because of strong trading in the battery division. This is a higher margin part of the business, and it will help to reduce the EBITDA loss from £1.6m to £900,000. The anticipated lifetime value of an existing US battery connectors client has been raised from £43m to at least £56.8m. The overall market remains difficult, though. A £520,000 R&D tax credit should be received in April and another payment of £250,000 should be received in the second half of 2025. Strip Tinning is on course to make a pre-tax profit in 2027. A grant is being applied for from the Automotive Transformation Fund. Strip Tinning will require more cash to fund growth. The share price initially more than doubled and ended the week 29.7% ahead at 24p.

Insurance premium finance provider Orchard Funding (LON: ORCH) reported an improvement in pre-tax profit from £1.08m to £2.1m. Impairment provisions fell from £490,000 to £60,000. Average income earning assets grew 9% to £67.9m. There is an interim dividend of 1p/share plus a special dividend of 1p/share. The company is sceptical about AIM, but it has no current plans to leave. The share price is 28.1% higher at 36.5p.

Zinnwald Lithium (LON: ZNWD) shares benefited from the announcement that the Saxony state government has recognised the company’s eponymous lithium project as a project of outstanding importance. The company recently published a pre-feasibility study showing a pre-tax NPV of €3.3bn with a mine life of 40 years. The shares recovered one-quarter to 6p, which is slightly lower than at the start of the previous week, when disappointment about the project not being on the list of 47 projected designated strategic by the EU led to a fall in the share price.

FALLERS

Electric Guitar (LON: ELEG) returned from suspension during the week after creditors agreed to the company voluntary arrangement and a £300,000 subscription at 0.034p/share. The company liquidated its operating subsidiary and is seeking a new business to acquire. The share price declined 64.6% to 0.085p.

Minoan Group (LON: MIN) says trading in the shares is likely to be suspended because it does not have enough cash to complete the audit of its accounts to October 2024. The suspension is expected on 1 May, but it may come earlier because of the lack of cash. Minoan has not been able to extend the secured loan, totalling £1.19m, provided by DAGG. A proposal from DAG includes the conversion of the loan into shares and an additional £4.44m cash injection in return for shares. Some members of DAGG would also write off £1.1m they are owed. DAGG wants to nominate management to take the company forward. Investor concern knocked 61.5% off the share price to 0.125p.

Celadon Pharmaceuticals (LON: CEL) said it has still not received funds following its draw down request from either of its credit facilities. The company is talking to other finance providers. There is support from creditors to enable the cannabis medicines developer to continue to trade in April, but cash is required. The share price continued its slide ending the week 43.8% lower at 4.5p.

Cloud software services provider CloudCoCo (LON: CLCO) reported growth in ecommerce sales helping overall revenues to rise 6% to £27.5m in the year to September 2024. The revenues of continuing operations improved from £6.19m to £8.74m, while the loss fell from £603,000 to £553,000. Disposals since the year end have reduced debt. The results were published just in time to prevent trading in the shares being suspended. The share price dipped 41.9% to 0.09p.

Aquis weekly movers: Samarkand leaving Aquis

Tectonic Gold (LON: TTAU) says farm-in partner White Energy has completed stage 1 of its spending commitment and earned a 51% interest in Specimen Hill. A further $1m of spending will earn a further 25%. White Energy can then pay $2m to buy the minority shareholding, although Tectonic Gold will retain a 3% perpetual net smelter royalty. There were no revenues in the six months to December 2024. There was £119,000 in cash at the end of 2024. The share price is one-third higher at 0.2p.

Ormonde Mining (LON: ORM) investee company TRU Precious Metals Corp is going to drill test a pipeline of exploration targets at the Golden Rose project that has been optioned by Eldorado Gold Corporation. The share price increased 10.7% to 0.155p.

Invinity Energy Systems LON: (IES) has reached agreement to proceed with the LODES project, which is a 21MWh VS3 system co-located with a solar array. The total cost of the project is £20m. Planning permission has to be adjusted before the project can commence construction and the project could be completed and operating in the second half of 2026. There should be some revenues recognised in 2025. A loss is still forecast for this year despite a jump in forecast revenues to £35.5m. The share price rose 6.06% to 8.75p.

Ananda Pharma (LON: ANA) has received approval from the Alfed Hospital Human Research Ethics Committee in Australia for its phase 1 pharmacokinetic study of the lead cannabinoid drug candidate MRX1. The first patient should be dosed in the third quarter of 2025. The data can support regulatory filings in other countries. The share price is 5.88% higher at 0.45p.

Jonathan Neame bought 4,000 shares in Shepherd Neame (LON: SHEP) at 490p each. Richard Oldfield acquired 20,800 shares at 485p each and 5,000 shares at 484p each. The share price edged up 4.12% to 505p.

FALLERS

Samarkand (LON: SMK) is asking for shareholder approval to leave Aquis. The ecommerce technology provider has adapted its strategy to focus on its own brands and is less dependent on the Chinese market for growth. The costs of being quoted will be saved. The plan is to leave on 7 May and move to a JP Jenkins matched bargains facility. Even before the announcement, the lack of liquidity meant that the board does not believe the share price reflects the value of the business and it fell a further 82.1% to 0.625p.

ChallengerX has changed its name to Nyce International (LON: NYCE). The share price declined 22.2% to 0.175p.

AIM-quoted drug discovery company ImmuPharma (LON: IMM) has agreed to extend the period of warrants in Aquis-quoted skincare technology developer Incanthera (LON: INC). The 7.27 million warrants are exercisable at 9.5p each and they will be extended until the end of September. ImmuPharma will pay Incanthera a profit share of 30% of the difference between exercise and market prices. Incanthera has agreed to pay creditors £380,000 in shares at 8.5p each. The Incanthera share price dipped 20.9% to 8.5p.

KR1 (LON: KR1) had net assets of 58.2p/share at the end of February 2025. During February there was £462,000 of income generated from digital assets. The share price slid 18.4% to 31p.

Mendell Helium (LON: MDH) says the option to acquire Kansas-based M3 Helium has been extended to the end of June 2025. In principle, there is an offload agreement in principle with Scout Energy for the Rost well. The proceeds of this will fund the Hugoton farm-in agreement fee. The share price is 18.2% lower at 2.25p.

Automotive electrification technology developer Equipmake (LON: EQIP) has secured a £5m cash injection from Caterpillar Inc via convertible loan. This has an annual interest charge of 10% and lasts until the end of March 2029. The conversion price is the lower of 3.125p and 80% of the average trailing 30-day share price. There is also a development agreement for electric drivetrain products. This concludes the strategic review. An agreement with wave energy technology company CorPower Ocean will generate £650,000 for the first phase of the development of a generator and SiC (silicon carbide) inverter system to accelerate the commercialisation of the wave energy equipment. The share price dipped 17.9% to 1.15p.

Marula Mining (LON: MARU) has received the first revenues from sales of copper concentrate from the Kinusi copper mine in Tanzania. The share price decreased 17.1% to 3.625p.

Ride video capture technology provider Visum Technologies (LON: VIS) has extended its contract with the Children’s Day Foundation Linnanmaki in Finland for a further three years. This should generate a total of £100,000 in revenues. In the six months to December 2024, revenues fell from £130,000 to £71,000. The loss was $325,000. The share price declined 16.7% to 0.125p.

EPE Special Opportunities (LON: EO.P) has launched a share buyback programme of up to 2% of the shares in issue. The share price slipped 3.23% to 150p.

AIM movers: Shuka Minerals extends convertible and refinancing proposal for Minoan

1

Shuka Minerals (LON: SKA) has agreed with AUO Commercial Brokerage to extend the availability period for the entire £2m of the unsecured convertible note instrument to March 2026. The new redemption date is March 2027. Shuka Minerals is making progress towards the acquisition of the Kabwe mine. AUO has yet to provide any of the funding. The conversion price is 15p/share. The share price is two-fifths higher at 3.5p.

Shares in currency services provider Argentex (LON: AGFX) are continuing their upward momentum following full year figures earlier in the week. Chief executive Jim Ormonde bought 320,338 shares at 46.8p each. The outcome for 2024 was better than expected. Cash generated from operating activities improved from £13.6m to £16.7m. However, Argentex still fell into loss and may not return to pre-tax profit this year. Investment in digital infrastructure will help long-term growth. The share price rose a further 8.24% to 46p.

Keras Resources (LON: KRS) says the Togo state-owned company that has a mining permit for the Nayega manganese mine has appointed a contact miner and agreed an offtake deal with Fujax. Keras has advisory and brokerage agreements that entitle it to an advisory fee of 1.5% of gross revenues generated by the Nayega mine for three years and 6% of gross revenues for brokerage services over the lesser of 3.5 years and 900,000 tonnes of manganese ore produced and sold. The share price improved 7.69% to 1.4p.

Video editing technology developer Blackbird (LON: BIRD) reported a dip in revenues from £1.94m to £1.61m because of a lost contract. Operating costs were reduced. There was a £2.4m outflow from operating activities and there is £3.77m of cash in the balance sheet. Blackbird has already gained around 100 subscribers to the online collaborative editing platform elevate.io since its recent full launch and there are more than one thousand users. Blackbird has secured total revenues of £960,000 for 2025. That is lower than the same time in the previous year because that included a deal for the Olympics. The share price recovered 7.41% to 3.625p.

FALLERS

Minoan Group (LON: MIN) says trading in the shares is likely to be suspended because it does not have enough cash to complete the audit of its accounts to October 2024. The suspension is expected on 1 May, but it may come earlier because of the lack of cash. Minoan has not bee able to extend the secured loan, totalling £1.19m, provided by DAGG. A proposal from DAG includes the conversion of the loan into shares and an additional £4.44m cash injection in return for shares. Some members of DAGG would also write off £1.1m they are owed. DAGG wants to nominate management to take the company forward. The share price slumped 61.5% to 0.125p.

Beowulf Mining (LON: BEM) has revealed the full terms of its previously announced fundraising. A placing and rights issue could raise up to £4m and a retail offer could raise up to £700,000 at 11/share. The first £100,000 of the retail offer is subject to clawback relating to the placing. The WRAP retail offer will have a subscription period between 16 April and 2 May. The share price declined 35% to 13p.

Cleantech Lithium (LON: CTL) says the special lithium operating contract application process for the Laguna Verde project is taking longer than anticipated. The response to the application was expected in early April, but there is not indication of when it will happen. The share price fell 5.13% to 9.25p.

FTSE 100 resilience disintegrates as banks sink, China announces retaliatory measures

The FTSE 100 showed remarkable resilience yesterday in the initial reaction to Donald Trump’s trade tariffs, outperforming most European and US indices.

However, this resilience disappeared on Friday as FTSE 100 banking shares crumbled, sending the index sharply lower. Barclays, HSBC, Lloyds, Standard Chartered and NatWest all fell more than 5%.

Standard Chartered is the FTSE 100’s biggest casualty of the tariffs, losing around 17% of its value over the past week.

There were also losses for mining stocks and oil majors on Friday, which culminated in sending London’s leading index down by more than 3%.

Selling picked up after reports that China would implement 34% retaliatory tariffs on US goods and trade restrictions on rare earths. Investors will fear that more countries follow suit and take retaliatory measures. Some European leaders have been vocal in their support for hitting back at Trump.

Meanwhile, Donald Trump has said he’s open to negotiation. Equity bulls will hope the bookmaker-style charts of tariffs revealed on Wednesday were a PR stunt for his core voter base and an extreme negotiating tactic that will spur favourable trade deals.

Whatever the underlying motives are, markets are taking the tariffs on face value after a period of complacency, and the reaction in global equities has been cataclysmic.

Some economists are now predicting a US recession.

“With markets having suffered their worst week in five years, investors were hiding under their duvet on Friday hoping the pain would go away,” said Russ Mould, investment director at AJ Bell. 

“Unfortunately, the relentless selling continued, with markets falling across Asia and Europe and futures prices implying the US will do the same when trading begins later on.

“There are so many moving parts that getting your head around the situation isn’t easy. With countless sectors set to be hit by tariffs, it’s difficult to know where to begin to comprehend the situation.”

US indices had their worst trading since the pandemic yesterday, and the selling showed little sign of easing. S&P 500 futures were 1% weaker in the premarket.

Legendary investor Bill Gross has warned against buying the dip. It appears, for today at least, investors are taking heed.

Cavendish enjoys strong growth in private markets

Cavendish plc, a leading UK investment bank, has reported expected revenues of approximately £55 million for the financial year ended 31 March 2025, in line with the previous year on a like-for-like basis.

The company maintained profitability throughout both halves of the financial year, demonstrating the appeal of its service offering across public and private markets.

Despite challenging market conditions, Cavendish increased its market share in public markets, completing the last UK IPO of 2024 and the first of 2025.

However, the general malaise in UK public markets has seen Cavendish increase their focus on the UK’s private markets where they have ongoing relationships with 150 UK private equity firms.

The firm said its private markets business delivered particularly strong revenue growth, reflecting the strength of its advisory capabilities and continued demand for high-quality execution in this segment.

Cavendish has recently opened offices in Manchester and Birmingham to strengthen their regional presence and better serve their private market clients.

The company enters the new financial year with £21 million in net cash and more active mandates than at the same point last year.

UK Deeptech, Quantum Computing, and PISCES with Amadeus Capital Partners

The UK Investor Magazine was delighted to welcome Nick Kingsbury, Partner at Amadeus Capital Partners, for a deep dive into early-stage UK deeptech companies and what the upcoming introduction of the PISCES private company trading venue means for the UK’s private markets.

Nick provides a fascinating insight into Amadeus Capital Partners’ investment strategy, paying particular attention to their approach to UK deeptech companies and the core characteristics they look for in portfolio companies.

We discuss a selection of exciting UK companies in the quantum computing space and the specific real-world solutions they provide.

The Private Intermittent Securities and Capital Exchange System, better known as PISCES, is set to launch this year in the UK, aiming to provide investors a venue for improved trading of unlisted shares.

We explore the purpose of PISCES, and Nick gives his views on the benefits for the UK’s private markets.